BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10749878)

  • 1. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.
    Chen RH; Ding WV; McCormick F
    J Biol Chem; 2000 Jun; 275(23):17894-9. PubMed ID: 10749878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis.
    Fischer L; Boland G; Tuan RS
    J Cell Biochem; 2002; 84(4):816-31. PubMed ID: 11835406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
    Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action.
    Hedgepeth CM; Conrad LJ; Zhang J; Huang HC; Lee VM; Klein PS
    Dev Biol; 1997 May; 185(1):82-91. PubMed ID: 9169052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.
    Garrido JL; Godoy JA; Alvarez A; Bronfman M; Inestrosa NC
    FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
    Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
    Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
    Orme MH; Giannini AL; Vivanco MD; Kypta RM
    Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A.
    Seeling JM; Miller JR; Gil R; Moon RT; White R; Virshup DM
    Science; 1999 Mar; 283(5410):2089-91. PubMed ID: 10092233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
    Williams CL; Noti JD
    Int J Oncol; 2001 Dec; 19(6):1227-33. PubMed ID: 11713593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.
    Yamamoto H; Kishida S; Uochi T; Ikeda S; Koyama S; Asashima M; Kikuchi A
    Mol Cell Biol; 1998 May; 18(5):2867-75. PubMed ID: 9566905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt participation in the Wnt signaling pathway through Dishevelled.
    Fukumoto S; Hsieh CM; Maemura K; Layne MD; Yet SF; Lee KH; Matsui T; Rosenzweig A; Taylor WG; Rubin JS; Perrella MA; Lee ME
    J Biol Chem; 2001 May; 276(20):17479-83. PubMed ID: 11278246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.